Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-mdm2
Tumor Suppressor Protein p53
Urinary Bladder Neoplasms
The cooperative effects of phenotypes determined by mdm-2, p53, and bcl-2 expression may predict survival in patients with muscle-invasive TCC of the bladder.